Apexigen Inc Stock Forecast, Predictions & Price Target

Analyst price target for APGN

Based on 2 analysts offering 12 month price targets for Apexigen Inc.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell APGN stock?

Based on 2 analysts offering ratings for Apexigen Inc.
Strong Buy
Strong Buy
2 analysts 100%
0 analysts 0%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their APGN stock forecasts and price targets.

APGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Roth Capital
Bottom 2%
Strong BuyReinstates$15.00+2,784.62%2023-01-24
EF Hutton
Bottom 7%
Strong BuyInitiates Coverage On$8.00+1,438.46%2023-01-05

1 of 1

APGN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
APGN$0.52$11.50+2,111.54%Strong Buy

Apexigen Stock Forecast FAQ

Is Apexigen Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: APGN) stock is to Strong Buy APGN stock.

Out of 2 analysts, 2 (100%) are recommending APGN as a Strong Buy, 0 (0%) are recommending APGN as a Buy, 0 (0%) are recommending APGN as a Hold, 0 (0%) are recommending APGN as a Sell, and 0 (0%) are recommending APGN as a Strong Sell.

If you're new to stock investing, here's how to buy Apexigen stock.

What is APGN's Price Target?

According to 2 Wall Street analysts that have issued a 1 year APGN price target, the average APGN price target is $11.50, with the highest APGN stock price forecast at $15.00 and the lowest APGN stock price forecast at $8.00.

On average, Wall Street analysts predict that Apexigen's share price could reach $11.50 by Jan 24, 2024. The average Apexigen stock price prediction forecasts a potential upside of 2,111.54% from the current APGN share price of $0.52.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.